Pediatrics

Showing 1-5 of 5 Results

  • Andy Wen

    Andy Wen

    Clinical Professor, Pediatrics - Critical Care

    BioDr. Andy Y. Wen joined the Division of Pediatric Critical Care Medicine at Stanford University School of Medicine in 2019. He received his B.A. degree in Molecular Biology & Biochemistry at Rutgers University, and his medical degree from Rutgers Robert Wood Johnson Medical School. He completed a Pediatrics Residency Training Program at the State University of New York Downstate Medical Center and a Pediatric Critical Care Medicine Fellowship Training Program at the University of California Los Angeles.

    After briefly working for Kaiser Permanente Southern California Permanente Medical Group, Dr. Wen joined the Division of Pediatric Critical Care at NYU School of Medicine. He assumed the role of Bellevue Hospital PICU medical director and helped to expand Bellevue's Pediatric Trauma Program and Pediatric Critical Care Transport Services for the New York City (NYC) public hospital system, NYC Health & Hospitals. During the 2014 to 2016 Ebola outbreak in West Africa, Dr. Wen was a member of the Special Pathogens Program at Bellevue Hospital, which was one of only four institutions in the US to treat a patient with Ebola and helped established the National Ebola Training and Education Center (NETEC).

    While at UCLA, Dr. Wen received a T32 Training Grant to perform research investigating the role of transcription factor CREB in innate immune function using a murine model for AML. At NYU, his research projects included analyzing transfusion practices in the PICU, quality improvement projects targeting patients at high risk for unplanned extubation, and exploring the utility of NIRS as an early predictor of seizure activity. Dr. Wen is a member of Pediatric Acute Lung Injury & Sepsis Investigators (PALISI) and has been involved in multi-center studies looking at critical care patients with Bronchiolitis and COVID-19. Dr. Wen is the USA Editor for Journal of Pediatric Intensive Care and has reviewed abstracts for PAS, SCCM, and AMIA. His educational efforts have included teaching Pediatric Fundamental Critical Care Support (PFCCS) courses, helping develop a Pediatric Residency Simulation course curriculum, and helping develop a Point-of-Care Ultrasound course for critical care advanced practice providers.

    At Stanford University School of Medicine, Dr. Wen is in charge of Regional Pediatric Critical Care Outreach with a goal to promote medical education and expand the Stanford Children’s Health network to improve access for sick children in need of high quality care. Dr. Wen provides clinical services at both John Muir Medical Center and Lucile Packard Children’s Hospital.

  • Yuhan Wen

    Yuhan Wen

    Postdoctoral Scholar, Critical Care Medicine

  • Julie Williamson, DO, FAAP

    Julie Williamson, DO, FAAP

    Clinical Professor, Anesthesiology, Perioperative and Pain Medicine
    Clinical Professor (By courtesy), Pediatrics - Critical Care

    BioDr. Williamson practices pediatric anesthesiology and critical care. She is committed to undergraduate and graduate medical education, and has served as an Educator-for-CARE at the Stanford School of Medicine and as a program director for Anesthesiology at Emory University. She is affiliated with several mentoring and advising programs, including the Stanford Anesthesiology Mentoring Program and the Women's Empowerment and Leadership Initiative for Pediatric Anesthesiologists.

  • Budi Wiryawan

    Budi Wiryawan

    Clinical Professor, Pediatrics - Critical Care

  • Mulate Zerihun Workeneh

    Mulate Zerihun Workeneh

    Postdoctoral Scholar, Critical Care

    BioDr. Mulate Zerihun Workeneh is a Postdoctoral Scholar in Dr. Bereketeab Haileselassie’s laboratory in the Department of Pediatrics at Stanford University School of Medicine. He earned a Ph.D. in Medical Sciences from the Azrieli Faculty of Medicine at Bar-Ilan University, Israel, where he developed peptide therapeutics that target mitochondrial protein-protein interactions involved in cardiovascular disease. Dr. Workeneh’s research uses medicinal chemistry, chemical biology, peptide engineering, computational modeling and mitochondrial biology to understand how the disease occurs and to develop new ways to treat it. During his doctoral training, he designed and evaluated novel linear and macrocyclic peptide inhibitors that alter mitochondrial dynamics to mitigate mitochondrial dysfunction and cardiovascular injury. His work at Stanford is focused on defining the role of mitochondrial dynamics in endothelial dysfunction in sepsis and multiple organ dysfunction syndrome (MODS). He is working to develop peptide-based therapeutics that maintain mitochondrial function, improve vascular health and prevent organ failure in critically ill patients by integrating approaches in chemical biology, molecular and cellular biology, and translational drug discovery. Dr. Workeneh has publications in leading medicinal chemistry, pharmacology, and mitochondrial biology journals and is an inventor on patents related to mitochondrial protein-protein interaction inhibitors. His goal is to translate advances in mitochondrial biology into first-in-class therapeutics for cardiovascular disease, sepsis, and other disorders linked to mitochondrial dysfunction. He is excited to work across disciplines at Stanford to help push biomedical research forward.